These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 26497550)
1. Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways. Zhao T; Hu F; Liu X; Tao Q Oncotarget; 2015 Nov; 6(34):35908-21. PubMed ID: 26497550 [TBL] [Abstract][Full Text] [Related]
2. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764 [TBL] [Abstract][Full Text] [Related]
3. miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo. Li J; Lei H; Xu Y; Tao ZZ PLoS One; 2015; 10(8):e0135265. PubMed ID: 26258591 [TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020 [TBL] [Abstract][Full Text] [Related]
5. Change of the expression of human telomerase reverse transcriptase mRNA and human telomerase RNA after cisplatin and 5-fluorouracil exposure in head and neck squamous cell carcinoma cell lines. Lee BJ; Lee BH; Wang SG; Lee JC; Roh HJ; Goh EK; Kim CM; Jun ES J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S73-8. PubMed ID: 17923759 [TBL] [Abstract][Full Text] [Related]
6. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer. Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420 [TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition. Zhao T; Hu F; Qiao B; Chen Z; Tao Q Int J Oncol; 2015 May; 46(5):2205-15. PubMed ID: 25775973 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma. Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095 [TBL] [Abstract][Full Text] [Related]
9. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
10. Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT. Jang KJ; Kwon GS; Jeong JW; Kim CH; Yoon HM; Kim GY; Shim JH; Moon SK; Kim WJ; Choi YH J Biosci Bioeng; 2015 Mar; 119(3):351-7. PubMed ID: 25282637 [TBL] [Abstract][Full Text] [Related]
11. Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas. Park YJ; Kim EK; Moon S; Hong DP; Bae JY; Kim J Anticancer Res; 2014 Nov; 34(11):6389-95. PubMed ID: 25368238 [TBL] [Abstract][Full Text] [Related]
12. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer. Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Xi L; Chen G; Zhou J; Xu G; Wang S; Wu P; Zhu T; Zhang A; Yang W; Xu Q; Lu Y; Ma D Apoptosis; 2006 May; 11(5):789-98. PubMed ID: 16554963 [TBL] [Abstract][Full Text] [Related]
14. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811 [TBL] [Abstract][Full Text] [Related]
15. Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies. Stein AP; Swick AD; Smith MA; Blitzer GC; Yang RZ; Saha S; Harari PM; Lambert PF; Liu CZ; Kimple RJ Cancer Med; 2015 May; 4(5):699-712. PubMed ID: 25619980 [TBL] [Abstract][Full Text] [Related]
16. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition. Ban MJ; Byeon HK; Yang YJ; An S; Kim JW; Kim JH; Kim DH; Yang J; Kee H; Koh YW Cancer Sci; 2018 Dec; 109(12):3816-3825. PubMed ID: 30343534 [TBL] [Abstract][Full Text] [Related]
18. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes]. Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947 [TBL] [Abstract][Full Text] [Related]
19. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma. Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686 [TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of silencing hTERT gene by short hairpin RNA on growth of human laryngeal squamous cell carcinoma xenograft in nude mice]. Liu D; Tao ZZ; Xiao BK; Chen SM; Chi HM Ai Zheng; 2006 Jan; 25(1):11-6. PubMed ID: 16405742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]